ERX Eirx Therap.

RNS Number:9159R
EiRx Therapeutics PLC
08 April 2008


Financial Services Authority




              TR-1 i: NOTIFICATION OF MAJOR INTERESTS IN SHARES


1.   Identity of the issuer or the underlying               Eirx Therapeutics Plc
     issuer of existing shares to which
     voting rights are attached ii:

2.   Reason for notification (please tick the appropriate box or boxes)

An acquisition or disposal of voting rights                                  X

An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached

An event changing the breakdown of voting rights


Other (please specify):


3.   Full name of person(s) subject to the
     notification obligation iii:

Barclays PLC

4.   Full name of shareholder(s) (if different from 3):

     Barclays Stockbrokers Ltd
                                                                             

5.   Date of transaction and date on which the threshold is
crossed or reached v:

07-Apr-08
                                                                             

6.   Date on which issuer notified:

08-Apr-08
                                                                              

7.   Threshold(s) that is/are crossed or reached:

8% to 7%


8.         Notified details:
A: Voting rights attached to shares


Class/type       Situation               Resulting situation after the triggering transaction vii
of shares        previous to the
                 Triggering
if possible      transaction vi
using the ISIN
CODE
                 Number      Number      Number          Number of Voting Rights     % of voting rights
                 Of          Of          Of
                 Shares      Voting      Shares
                             Rights viii                   Direct x     Indirect xi    Direct    Indirect

    GB00B0XQBS97 615,535,328 615,535,328     525,637,053             0   525,637,053       0.00       7.54


B: Financial Instruments

Resulting situation after the triggering transaction xii

Type of financial   Expiration       Exercise/Conversion     No. of voting         Percentage of voting
instrument                           Period/Date xiv                               rights
                    date xiii                                rights that may be
                                                             acquired if the
                                                             instrument exercised/
                                                             converted

N/A                 N/A              N/A                     N/A                   N/A


Total (A+B)
Number of voting rights                             Percentage of voting rights

         525,637,053                                              7.54



9.   Chain of controlled undertakings through which the voting rights and /or
the financial instruments are effectively held, if applicable xv :

Barclays Stockbrokers Ltd



Proxy Voting:

10. Name of proxy holder:                           N/A

11. Number of voting rights proxy holder will cease N/A
    to hold:

12. Date on which proxy holder will cease to hold   N/A
    voting rights:


13. Additional information:                          N/A

14. Contact name:                                 Geoff Smith

15. Contact telephone number                      020 7116 2913




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

HOLUWONRWBRSRAR

Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024